Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Nemeth

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nephron. Clinical Practice|November 13, 2010
Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysisZ Kiss, C Ambrus, C Almasi, et al.
Journal of Orofacial Pain|October 22, 1998
Effects of major Class II occlusal corrections on temporomandibular signs and symptomsR C Rodrigues-Garcia, S Sakai, J D Rugh, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nephron. Clinical Practice|November 13, 2010
Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysisZ Kiss, C Ambrus, C Almasi, et al.
Journal of Orofacial Pain|October 22, 1998
Effects of major Class II occlusal corrections on temporomandibular signs and symptomsR C Rodrigues-Garcia, S Sakai, J D Rugh, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Pageof 2